Virtu Financial LLC Buys Shares of 16,625 Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Virtu Financial LLC purchased a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 16,625 shares of the company’s stock, valued at approximately $279,000.

Several other institutional investors and hedge funds have also recently modified their holdings of GRDN. Seven Grand Managers LLC purchased a new stake in shares of Guardian Pharmacy Services during the 3rd quarter valued at approximately $2,515,000. Allspring Global Investments Holdings LLC purchased a new stake in Guardian Pharmacy Services in the third quarter valued at $5,460,000. Stephens Inc. AR acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $189,000. Royce & Associates LP purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $1,260,000. Finally, Foundry Partners LLC acquired a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth about $1,680,000.

Insider Buying and Selling at Guardian Pharmacy Services

In other news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the company’s stock in a transaction on Friday, September 27th. The shares were bought at an average cost of $14.00 per share, with a total value of $499,996.00. Following the transaction, the director now owns 35,714 shares in the company, valued at approximately $499,996. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven D. Cosler acquired 7,000 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were purchased at an average cost of $21.22 per share, with a total value of $148,540.00. Following the completion of the transaction, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. The trade was a 65.34 % increase in their position. The disclosure for this purchase can be found here.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of recent analyst reports. Stephens started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price on the stock. Raymond James began coverage on shares of Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective for the company. Finally, Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $22.54 on Wednesday. The stock’s 50-day simple moving average is $20.85. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $25.74.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19). The business had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. As a group, analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.